Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelivaptan HPA Axis Study in MDD
NCT01606384Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2006
- Primary completion
- Aug 2007
- Modality
- Allosteric Modulators, Orthosteric Ligands, Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of nelivaptan in major depressive disorder (MDD), sponsored by Sanofi. Started Dec 2006; status: completed.
02
Drugs
nelivaptan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01606384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606384.